Literature DB >> 32550448

Genetic mapping of EgfrL.3.1 in Drosophila melanogaster.

Joyce Stamm1, Gnanda Joshi2, M A Anderson2, Katie Bussing1, Colton Houchin1, Amber Elinsky2, Jacob Flyte2, Nadine Husseini2, Dominika Jarosz2, Chelsea Johnson2, Abby Johnson2, Christina Jones2, Taj Kooner2, Daniel Myhre1, Thomas Rafaill2, Sarah Sayed2, Kirby Swan2, Jonathan Toma2, Jacob Kagey2.   

Abstract

Entities:  

Year:  2019        PMID: 32550448      PMCID: PMC7252331          DOI: 10.17912/micropub.biology.000098

Source DB:  PubMed          Journal:  MicroPubl Biol        ISSN: 2578-9430


× No keyword cloud information.
A. Mosaic (FRT42D Dark), and Dark Egfr (FRT42D Dark) eyes. In both eyes the homozygous mutant tissue is pigmented (w). B. Region of chromosome 2R that failed to complement L.3.1 by deficiency mapping (2R:21,497,290..21,806,350). Arrow denotes location of Egfr gene. B is adapted from flybase.org (Gramates et al., 2017).

Description

An EMS screen was conducted utilizing the Flp/FRT system to identify mutations that caused an array of phenotypic alterations in the size of the eye including the ratio of mutant to wild type tissue (red over white) or the developmental patterning of the mosaic eye. This screen was done in the genetic background of blocked apoptosis in the homozygous mutant cells to identify conditional regulators of cell growth and eye development (Kagey et al., 2012). The block in apoptosis in the mosaic mutant tissue was achieved by using a FRT42D Darkchromosome as a starting point for the EMS mutagenesis (Akdemir et al., 2006). The Dark allele was generated by an imprecise excision of the P{lacW}ArkCD4, this allele retains the w (Akdemir et al., 2006) One of the mutants identified was L.3.1 which generated a small rough eye mosaic phenotype, with a smaller percentage of pigmented tissue than the FRT42D, Darkcontrol (Figure 1A). The Darkmosaic eye is approximately 60% pigmented tissue, while the Dark mosaic eye was smaller overall and approximately 50% mutant tissue (w). The ‘rough eye’ phenotype indicates a disruption in the ommatidial organization. In both images the pigmented (w) tissue is homozygous mutant and the unpigmented tissue is homozygous wild type.
Figure 1.

A. Mosaic (FRT42D Dark), and Dark Egfr (FRT42D Dark) eyes. In both eyes the homozygous mutant tissue is pigmented (w). B. Region of chromosome 2R that failed to complement L.3.1 by deficiency mapping (2R:21,497,290..21,806,350). Arrow denotes location of Egfr gene. B is adapted from flybase.org (Gramates et al., 2017).

The genetic mapping of the location of mutant L.3.1 was done by two independent groups of undergraduate researchers at the University of Detroit Mercy and University of Evansville in undergraduate genetics laboratory courses as part of the Fly-CURE consortium (Bieser et al., 2018). Complementation mapping was conducted independently and the results confirmed between groups. Virgin females from the FRT42D L.3.1 Dark stock were mated in series to male flies from the 87 deficiency stocks that comprise the Bloomington Stock Center 2R Deficiency Kit (only stocks distal to the FRT42D site were used for mapping) (Cook et al., 2012). Mutant L.3.1 failed to complement Deficiency stock Df(2R)BSC664 (2R:21,341,647..21,872,028), while complementing the flanking overlapping deficiencies Df(2R)BSC821 and Df(2R)BSC597. This left a region of failure to complement of 2R:21,497,290..21,806,350, which is pictured above in Figure 1 B. Lethal alleles of candidate genes within this region were mated independently to L.3.1 to test for complementation. L.3.1 failed to complement an apparent loss of function allele EgfrDworkin et. al. 2006), indicating that L.3.1 is likely a novel Egfr allele, Egfr

Reagents

FRT42D Dark (Akdemir et al., 2006) FRT42D Dark (this manuscript) Ey>Flp; FRT42D (BDSC 5616) y; P{w=lacW}Egfr/CyO (BDSC 10385) Bloomington Drosophila Stock Center 2R Deficiency Kit (Cook et al., 2012): w Df(2R)BSC664/SM6a w; Df(2R)BSC821, P+PBac{ w =XP3.RB5}BSC821/SM6a w Df(2R)BSC597/SM6a
  6 in total

1.  The mapping of Drosophila melanogaster mutant A.4.4.

Authors:  Kayla Bieser; Joyce Stamm; Ayala Aldo; Suneil Bhaskara; Makayla Clairborne; Joselyn Coronel Gómez; Ron Dean; Aaron Dowell; Evan Dowell; Mathew Eissa; Ahmad Fawaz; Michael Fouad-Meshriky; Dustin Godoy; Krista Gonzalez; Malak Hachem; Malak Hammoud; Anthony Huffman; Hunter Ingram; Alex Jackman; Bibek Karki; Natalia Khalil; Houda Khalil; Tran Khanh Ha; Arjun Kharel; Izabell Kobylarz; Hunter Lomprey; Adam Lonnberg; Safa Mahbuba; Hend Massarani; Madeline Minster; Krystina Molina; Lynette Molitor; Taylor Murray; Payal Patel; Sydney Pechulis; Architha Raja; Gladys Rastegari; Skylar Reeves; Niveda Sabu; Rafael Salazar; Devan Schulert; Matthew Senopole; Kristen Sportiello; Claudia Torres; Jade Villalobos; Joseph Wu; Stacy Zeigler; Jacob Kagey
Journal:  MicroPubl Biol       Date:  2018-12-17

2.  Epidermal growth factor receptor and transforming growth factor-beta signaling contributes to variation for wing shape in Drosophila melanogaster.

Authors:  Ian Dworkin; Greg Gibson
Journal:  Genetics       Date:  2006-04-28       Impact factor: 4.562

3.  Regulation of Yorkie activity in Drosophila imaginal discs by the Hedgehog receptor gene patched.

Authors:  Jacob D Kagey; Jordan A Brown; Kenneth H Moberg
Journal:  Mech Dev       Date:  2012-06-15       Impact factor: 1.882

4.  Autophagy occurs upstream or parallel to the apoptosome during histolytic cell death.

Authors:  Fatih Akdemir; Robert Farkas; Po Chen; Gabor Juhasz; Lucia Medved'ová; Miklos Sass; Lai Wang; Xiaodong Wang; Suganthi Chittaranjan; Sharon M Gorski; Antony Rodriguez; John M Abrams
Journal:  Development       Date:  2006-03-15       Impact factor: 6.868

5.  The generation of chromosomal deletions to provide extensive coverage and subdivision of the Drosophila melanogaster genome.

Authors:  R Kimberley Cook; Stacey J Christensen; Jennifer A Deal; Rachel A Coburn; Megan E Deal; Jill M Gresens; Thomas C Kaufman; Kevin R Cook
Journal:  Genome Biol       Date:  2012       Impact factor: 17.906

6.  FlyBase at 25: looking to the future.

Authors:  L Sian Gramates; Steven J Marygold; Gilberto Dos Santos; Jose-Maria Urbano; Giulia Antonazzo; Beverley B Matthews; Alix J Rey; Christopher J Tabone; Madeline A Crosby; David B Emmert; Kathleen Falls; Joshua L Goodman; Yanhui Hu; Laura Ponting; Andrew J Schroeder; Victor B Strelets; Jim Thurmond; Pinglei Zhou
Journal:  Nucleic Acids Res       Date:  2016-10-30       Impact factor: 16.971

  6 in total
  3 in total

1.  Genetic mapping of shnE.3.2 in Drosophila melanogaster.

Authors:  Kayla Bieser; Jamie Sanford; Ken Saville; Katherine Arreola; Zachary Ayres; David Basulto; Serena Benito; Christopher Breen; Julian Brix; Nicole Brown; Krissa Burton; Taree Chadwick; Matthew Chen; Katherine Chu; Beverly Corbett; Zerrick Dill; Meghan Faughender; Ashlynn Hickey; Joshua Julia; Shannon Kelty; Briggette Jobs; Bryce Krason; Brian Lam; Colin McCullough; Bryanna McEwen; Julian McKenzie; Kayla McQuinn; Chloe Moritz; Kristina Myers; Elizabeth Naugle; Ashley Nutter; Danielle O'Conke; Megan O'Grondik; Kriya Patel; Sydney Rudowski; Emma Sberna; Gunner Stall; Tad Steiner; Eda Tanriverdi; Natalie Torres Patarroyo; Virginia Traster; Leo Tsai; Andrew Valenti; Mariela Villegas; Samantha Voors; Kierra Watson; Megan Wright; Jacob Kagey
Journal:  MicroPubl Biol       Date:  2019-06-05

2.  speck, First Identified in Drosophila melanogaster in 1910, Is Encoded by the Arylalkalamine N-Acetyltransferase (AANAT1) Gene.

Authors:  Eric P Spana; Amanda B Abrams; Katharine T Ellis; Jason C Klein; Brandon T Ruderman; Alvin H Shi; Daniel Zhu; Andrea Stewart; Susan May
Journal:  G3 (Bethesda)       Date:  2020-09-02       Impact factor: 3.154

3.  B.2.16 is a non-lethal modifier of the Dark82 mosaic eye phenotype in Drosophila melanogaster.

Authors:  Alysia D Vrailas-Mortimer; Nitish Aggarwal; Neha N Ahmed; Ian M Alberts; Masa Alhawasli; Ibrahim A Aljerdi; Brooke M Allen; Ahmad M Alnajar; Michael A Anderson; Ryan Armstong; Chace C Avery; Eric J Avila; Tyra N Baker; Soolmaz Basardeh; Natasha A Bates; Farrah N Beidas; Ashton C Bosler; Deja M Brewer; Ryan S Buenaventura; Natalie Jl Burrell; Alyn P Cabrera-Lopez; Amairani B Cervantes-Gonzalez; Raymond P Cezar; Joselyn Coronel; Corinne Croslyn; Konnor R Damery; Lucero Diaz-Alavez; Nupur P Dixit; Dilcia L Duarte; Amanda R Emke; Katherine English; Audrey A Eshun; Samuel R Esterly; Arnold J Estrada; Mark Feng; Meghan M Freund; Niko Garcia; Charandeep S Ghotra; Haddia Ghyasi; Christa Sa Hale; Luci Hulsman; Lindsey Jamerson; Austin K Jones; Madeline Kuczynski; Takailah N Lacey-Kennedy; Mindy J Lee; Tala Mahjoub; Molly C Mersinger; Alyssa D Muckerheide; David W Myers; Karen Nielsen; Paul J Nosowicz; Jacinda A Nunez; Amy C Ortiz; Tulsi T Patel; Natalie N Perry; W Storm A Poser; Deisy M Puga; Cathrine Quam; Paulina Quintana-Lopez; Piper Rennerfeldt; Nicholas M Reyes; Ian G Rines; Cally Roberts; Daniel B Robinson; Kalina M Rossa; Gloria J Ruhlmann; Jeremy Schmidt; John R Sherwood; Dimyana H Shonoda; Hannah Soellner; Juan C Torrez; Mayukah Velide; Zachary Weinzapfel; Alisa C Ward; Kayla L Bieser; Julie A Merkle; Joyce C Stamm; Richard L Tillett; Jacob D Kagey
Journal:  MicroPubl Biol       Date:  2021-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.